E303-1001S: A Phase I/II, Open-label, Multi-center, First-in-human Trial to Investigate E303 in Participants with Unresectable or Metastatic Solid Tumors and Urothelial Carcinoma
-
Enrollment
This study is not currently enrolling. -
Research Area
Clinical Cancer Research -
Sponsor
Samsung Bioepis Co., Ltd.